Team:Goettingen/Team/DAC

From 2013.igem.org

(Difference between revisions)
Line 39: Line 39:
<html>
<html>
<p>Another approach of our project is the determination of the 3D structure of diadenylate cyclase (DAC) from the human pathogenic bacterium <i>Listeria monocytogenes</i> by crystallography. Due to the fact that the DAC from the closely related bacterium <i>Bacillus subtilis</i> is difficult to purify and thus to crystallize, we have decided to crystallize the DAC protein from <i>Listeria</i>. In addition to this, we will try to crystallize the DACs from other Gram-positive bacteria like <i>Streptococcus</i> and <i>Staphylococcus</i> .</p>
<p>Another approach of our project is the determination of the 3D structure of diadenylate cyclase (DAC) from the human pathogenic bacterium <i>Listeria monocytogenes</i> by crystallography. Due to the fact that the DAC from the closely related bacterium <i>Bacillus subtilis</i> is difficult to purify and thus to crystallize, we have decided to crystallize the DAC protein from <i>Listeria</i>. In addition to this, we will try to crystallize the DACs from other Gram-positive bacteria like <i>Streptococcus</i> and <i>Staphylococcus</i> .</p>
-
<p>Once having a 3D structure of a protein in hand potential inhibitor binding sites can be identified by computational modeling. Moreover, a functional DAC can be used to design a powerful <i>in vitro</i> screening system in order to identify potent inhibitors of the enzyme. Promising inhibitors that interfere with DAC activity could be used as a starting point for the development of drugs with improved inhibitory efficiency.</p>
+
<p>Once having a 3D structure of a protein in hand potential inhibitor binding sites can be identified by computational modeling. Moreover, a functional DAC can be used to develop a powerful <i>in vitro</i> screening system in order to identify potent inhibitors of the enzyme. Promising inhibitors that interfere with DAC activity could be used as a starting point for the development of drugs with improved inhibitory efficiency.</p>
</html>
</html>

Revision as of 18:38, 29 September 2013





The beast and its Achilles heel:

 A novel target to fight multi-resistant pathogenic bacteria



DAC Team

Another approach of our project is the determination of the 3D structure of diadenylate cyclase (DAC) from the human pathogenic bacterium Listeria monocytogenes by crystallography. Due to the fact that the DAC from the closely related bacterium Bacillus subtilis is difficult to purify and thus to crystallize, we have decided to crystallize the DAC protein from Listeria. In addition to this, we will try to crystallize the DACs from other Gram-positive bacteria like Streptococcus and Staphylococcus .

Once having a 3D structure of a protein in hand potential inhibitor binding sites can be identified by computational modeling. Moreover, a functional DAC can be used to develop a powerful in vitro screening system in order to identify potent inhibitors of the enzyme. Promising inhibitors that interfere with DAC activity could be used as a starting point for the development of drugs with improved inhibitory efficiency.

 

Previous Next


Retrieved from "http://2013.igem.org/Team:Goettingen/Team/DAC"